ID   ADA1B_RAT               Reviewed;         515 AA.
AC   P15823; Q63215;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=Alpha-1B adrenergic receptor;
DE   AltName: Full=Alpha-1B adrenoreceptor;
DE            Short=Alpha-1B adrenoceptor;
GN   Name=Adra1b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=2156222; DOI=10.1093/nar/18.4.1053;
RA   Voigt M.M., Kispert J., Chin H.;
RT   "Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor.";
RL   Nucleic Acids Res. 18:1053-1053(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1706716; DOI=10.1016/s0021-9258(18)38126-2;
RA   Lomasney J.W., Cotecchia S., Lorenz W., Leung W.-Y., Schwinn D.A.,
RA   Yang-Feng T.L., Brownstein M., Lefkowitz R.J., Caron M.G.;
RT   "Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic
RT   receptor. The gene for which is located on human chromosome 5.";
RL   J. Biol. Chem. 266:6365-6369(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8406017; DOI=10.1016/0378-1119(93)90300-r;
RA   Gao B., Kunos G.;
RT   "Isolation and characterization of the gene encoding the rat alpha 1B
RT   adrenergic receptor.";
RL   Gene 131:243-247(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-253.
RX   PubMed=7989580; DOI=10.1172/jci117587;
RA   Kanasaki M., Matsubara H., Murasawa S., Masaki H., Nio Y., Inada M.;
RT   "cAMP responsive element-mediated regulation of the gene transcription of
RT   the alpha 1B adrenergic receptor by thyrotropin.";
RL   J. Clin. Invest. 94:2245-2254(1994).
CC   -!- FUNCTION: This alpha-adrenergic receptor mediates its action by
CC       association with G proteins that activate a phosphatidylinositol-
CC       calcium second messenger system. Its effect is mediated by G(q) and
CC       G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate
CC       phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homo- and heterooligomer. Heterooligomerizes with ADRA1B
CC       homooligomers in cardiac myocytes. Interacts with CAVIN4.
CC       {ECO:0000250|UniProtKB:P35368}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell membrane
CC       {ECO:0000250|UniProtKB:P35368}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:P35368}. Membrane,
CC       caveola {ECO:0000250|UniProtKB:P35368}. Note=Location at the nuclear
CC       membrane facilitates heterooligomerization and regulates ERK-mediated
CC       signaling in cardiac myocytes. Colocalizes with GNAQ, PLCB1 as well as
CC       LAP2 at the nuclear membrane of cardiac myocytes (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Adrenergic receptor subfamily. ADRA1B sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X51585; CAA35934.1; -; mRNA.
DR   EMBL; M60655; AAA63478.1; -; mRNA.
DR   EMBL; L08610; AAA40647.1; -; Genomic_DNA.
DR   EMBL; L08609; AAA40647.1; JOINED; Genomic_DNA.
DR   EMBL; D32045; BAA06806.1; -; Genomic_DNA.
DR   PIR; JC1525; JC1525.
DR   AlphaFoldDB; P15823; -.
DR   SMR; P15823; -.
DR   DIP; DIP-59867N; -.
DR   IntAct; P15823; 1.
DR   STRING; 10116.ENSRNOP00000073309; -.
DR   BindingDB; P15823; -.
DR   ChEMBL; CHEMBL315; -.
DR   DrugCentral; P15823; -.
DR   GuidetoPHARMACOLOGY; 23; -.
DR   GlyCosmos; P15823; 3 sites, No reported glycans.
DR   GlyGen; P15823; 3 sites.
DR   iPTMnet; P15823; -.
DR   PhosphoSitePlus; P15823; -.
DR   SwissPalm; P15823; -.
DR   UCSC; RGD:2054; rat.
DR   AGR; RGD:2054; -.
DR   RGD; 2054; Adra1b.
DR   InParanoid; P15823; -.
DR   PhylomeDB; P15823; -.
DR   Reactome; R-RNO-390696; Adrenoceptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   PRO; PR:P15823; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0004937; F:alpha1-adrenergic receptor activity; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:RGD.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; ISO:RGD.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0005980; P:glycogen catabolic process; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0045818; P:negative regulation of glycogen catabolic process; ISO:RGD.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:MGI.
DR   GO; GO:0150099; P:neuron-glial cell signaling; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0045819; P:positive regulation of glycogen catabolic process; ISO:RGD.
DR   GO; GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0001997; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; ISO:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IEA:InterPro.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEA:InterPro.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IMP:RGD.
DR   GO; GO:0043278; P:response to morphine; ISO:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0001987; P:vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   CDD; cd15326; 7tmA_alpha1B_AR; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR002233; ADR_fam.
DR   InterPro; IPR001115; ADRA1B_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF17; ALPHA-1B ADRENERGIC RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01103; ADRENERGICR.
DR   PRINTS; PR00556; ADRENRGCA1BR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cytoplasm; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Nucleus; Palmitate; Phosphoprotein;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..515
FT                   /note="Alpha-1B adrenergic receptor"
FT                   /id="PRO_0000069072"
FT   TOPO_DOM        1..45
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        46..70
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        71..83
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        84..105
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        106..115
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        116..141
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        142..161
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        162..182
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        183..201
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        202..224
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        225..295
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        296..319
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        320..326
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        327..351
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        352..515
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          392..430
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          474..515
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           368..378
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        405..423
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        481..502
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         264
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97717"
FT   LIPID           365
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        24
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        34
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        118..195
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        114..116
FT                   /note="GRI -> LSF (in Ref. 2; AAA63478)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        203
FT                   /note="Y -> C (in Ref. 1 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="S -> C (in Ref. 1 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        306
FT                   /note="C -> S (in Ref. 3; AAA40647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415..416
FT                   /note="TQ -> QK (in Ref. 1; CAA35934)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        440
FT                   /note="C -> Y (in Ref. 3; AAA40647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        484..486
FT                   /note="GDT -> ATA (in Ref. 1; CAA35934)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        493
FT                   /note="T -> S (in Ref. 3; AAA40647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        511
FT                   /note="A -> G (in Ref. 1; CAA35934)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   515 AA;  56586 MW;  AF0C3759F80C3135 CRC64;
     MNPDLDTGHN TSAPAHWGEL KDDNFTGPNQ TSSNSTLPQL DVTRAISVGL VLGAFILFAI
     VGNILVILSV ACNRHLRTPT NYFIVNLAIA DLLLSFTVLP FSATLEVLGY WVLGRIFCDI
     WAAVDVLCCT ASILSLCAIS IDRYIGVRYS LQYPTLVTRR KAILALLSVW VLSTVISIGP
     LLGWKEPAPN DDKECGVTEE PFYALFSSLG SFYIPLAVIL VMYCRVYIVA KRTTKNLEAG
     VMKEMSNSKE LTLRIHSKNF HEDTLSSTKA KGHNPRSSIA VKLFKFSREK KAAKTLGIVV
     GMFILCWLPF FIALPLGSLF STLKPPDAVF KVVFWLGYFN SCLNPIIYPC SSKEFKRAFM
     RILGCQCRGG RRRRRRRRLG ACAYTYRPWT RGGSLERSQS RKDSLDDSGS CMSGTQRTLP
     SASPSPGYLG RGTQPPVELC AFPEWKPGAL LSLPEPPGRR GRLDSGPLFT FKLLGDPESP
     GTEGDTSNGG CDTTTDLANG QPGFKSNMPL APGHF
//
